Giovanni Parmigiani

Giovanni Parmigiani's AcademicInfluence.com Rankings

Giovanni Parmigiani

Mathematics

#5882

World Rank

#8235

Historical Rank

Statistics

#476

World Rank

#550

Historical Rank

Measure Theory

#1023

World Rank

#1318

Historical Rank

mathematics Degrees

Download Badge

Mathematics

Giovanni Parmigiani's Degrees

PhD Biostatistics University of Milan
Masters Biostatistics University of Milan
Bachelors Statistics University of Milan

Why Is Giovanni Parmigiani Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Giovanni Parmigiani is a biostatistician. He is a professor of biostatistics at both the Dana–Farber Cancer Institute and the Harvard T.H. Chan School of Public Health, and is also associate director for population sciences at the Dana-Farber/Harvard Cancer Center. He is a fellow of the American Statistical Association. In 2009 he and his co-author Lurdes Inoue received a DeGroot Prize from the International Society for Bayesian Analysis for their book Decision Theory: Principles and Approaches.

(See a Problem?)

Giovanni Parmigiani's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

An Integrated Genomic Analysis of Human Glioblastoma Multiforme (2008) (4366)
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses (2008) (3758)
The Consensus Coding Sequences of Human Breast and Colorectal Cancers (2006) (2878)
The Genomic Landscapes of Human Breast and Colorectal Cancers (2007) (2549)
Meta-analysis of BRCA1 and BRCA2 penetrance. (2007) (1682)
The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. (1997) (1190)
Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene (2009) (788)
Comparative lesion sequencing provides insights into tumor evolution (2008) (771)
Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. (1998) (745)
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma (2014) (743)
The Genetic Landscape of the Childhood Cancer Medulloblastoma (2011) (711)
Familial Risk and Heritability of Cancer Among Twins in Nordic Countries. (2016) (578)
Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome Sequencing (2012) (568)
Mutational Analysis of the Tyrosine Phosphatome in Colorectal Cancers (2004) (533)
BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. (2002) (488)
Analysis of the human protein interactome and comparison with yeast, worm and fly interaction datasets (2006) (473)
Human L1 Retrotransposition Is Associated with Genetic Instability In Vivo (2002) (445)
A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro. (2009) (418)
Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers (2008) (403)
Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. (1997) (380)
Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma (2012) (379)
Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation (2013) (374)
Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. (2007) (348)
Large Deviation Techniques in Decision, Simulation and Estimation (1992) (333)
Mutational analysis of the tyrosine kinome in colorectal cancers. (2003) (330)
SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer (2009) (329)
Only three driver gene mutations are required for the development of lung and colorectal cancers (2014) (325)
Characterization of BRCA1 and BRCA2 mutations in a large United States sample. (2006) (316)
ComBat-seq: batch effect adjustment for RNA-seq count data (2020) (311)
BRCA1 Recruitment to Transcriptional Pause Sites Is Required for R-Loop-Driven DNA Damage Repair (2015) (306)
Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers (2008) (300)
Multiple shrinkage and subset selection in wavelets (1998) (295)
Prediction of germline mutations and cancer risk in the Lynch syndrome. (2006) (293)
Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts. (2006) (267)
Genome‐wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: Insights into distinctive pathogenesis (2007) (245)
Decision Theory: Principles and Approaches (2009) (239)
Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis (2020) (226)
Detection of mitochondrial DNA mutations in pancreatic cancer offers a "mass"-ive advantage over detection of nuclear DNA mutations. (2001) (226)
Toll-like receptor 3 and geographic atrophy in age-related macular degeneration. (2008) (223)
FDR and Bayesian Multiple Comparisons Rules (2006) (219)
A Cross-Study Comparison of Gene Expression Studies for the Molecular Classification of Lung Cancer (2004) (214)
The Predictive Capacity of Personal Genome Sequencing (2012) (213)
Pre-processing Agilent microarray data (2007) (203)
Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients. (2004) (198)
Mutational Analysis of the Tyrosine Kinome in Colorectal Cancers (2003) (188)
PancPRO: risk assessment for individuals with a family history of pancreatic cancer. (2007) (188)
Prevalence of somatic alterations in the colorectal cancer cell genome (2002) (185)
The Analysis of Gene Expression Data (2003) (180)
Risk prediction for late-stage ovarian cancer by meta-analysis of 1525 patient samples. (2014) (176)
Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression. (2002) (174)
curatedOvarianData: clinically annotated data for the ovarian cancer transcriptome (2013) (174)
Optimal Sample Size for Multiple Testing (2004) (173)
Prediction via Orthogonalized Model Mixing (1996) (165)
A statistical framework for expression‐based molecular classification in cancer (2002) (157)
Systematic Review: Gene Expression Profiling Assays in Early-Stage Breast Cancer (2008) (155)
Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer (2008) (154)
Optimal Design via Curve Fitting of Monte Carlo Experiments (1995) (150)
A multidimensional analysis of genes mutated in breast and colorectal cancers. (2007) (148)
Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma (2013) (144)
Performing cost-effectiveness analysis by integrating randomized trial data with a comprehensive decision model: application to treatment of acute ischemic stroke. (1999) (139)
Optimal Sample Size for Multiple Testing : the Case of Gene Expression Mi roarraysPeter (2004) (139)
Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma. (2005) (138)
The Analysis of Gene Expression Data: Methods and Software (2013) (136)
Adaptive platform trials: definition, design, conduct and reporting considerations (2019) (132)
Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers (2009) (130)
Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history. (1998) (127)
Genetic mutations associated with cigarette smoking in pancreatic cancer. (2009) (126)
Differentiation of a Highly Tumorigenic Basal Cell Compartment in Urothelial Carcinoma (2009) (125)
Bayesian Effect Estimation Accounting for Adjustment Uncertainty (2012) (124)
The genome and transcriptomes of the anti-tumor agent Clostridium novyi-NT (2006) (123)
Adaptive Randomization of Neratinib in Early Breast Cancer. (2016) (119)
Identification of a Gene Expression Profile That Differentiates Between Ischemic and Nonischemic Cardiomyopathy (2004) (115)
The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions (2012) (114)
Comparative meta-analysis of prognostic gene signatures for late-stage ovarian cancer. (2014) (107)
Identification of gene expression changes associated with the progression of retinal degeneration in the rd1 mouse. (2004) (100)
Estrogen Receptor/Progesterone Receptor-Negative Breast Cancers of Young African-American Women Have a Higher Frequency of Methylation of Multiple Genes than Those of Caucasian Women1 (2004) (99)
Penetrance of ATM Gene Mutations in Breast Cancer: A Meta‐Analysis of Different Measures of Risk (2016) (99)
DeMix: deconvolution for mixed cancer transcriptomes using raw measured data (2013) (98)
Targeting Vascular and Avascular Compartments of Tumors with C. novyi-NT and Anti-microtubule Agents (2004) (92)
Bayesian adaptive randomized trial design for patients with recurrent glioblastoma. (2012) (91)
BayesMendel: an R Environment for Mendelian Risk Prediction (2004) (90)
The Analysis of Gene Expression Data: An Overview of Methods and Software (2003) (89)
A Markov Chain Monte Carlo Technique for Identification of Combinations of Allelic Variants Underlying Complex Diseases in Humans (2005) (89)
Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families (2002) (88)
Design and analysis issues in genome-wide somatic mutation studies of cancer. (2009) (87)
Impact of gene expression profiling tests on breast cancer outcomes. (2007) (83)
Gene expression patterns in dendritic cells infected with measles virus compared with other pathogens. (2006) (82)
A Comparison of Alternative Models Applied to Stroke (1998) (82)
Meta-Analysis of Migraine Headache Treatments: Combining Information from Heterogeneous Designs (1999) (81)
Cross-study validation for the assessment of prediction algorithms (2014) (80)
Patient-oriented gene set analysis for cancer mutation data (2010) (79)
Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancer (2017) (79)
The clinical trials landscape for glioblastoma: is it adequate to develop new treatments? (2018) (75)
CoGAPS: an R/C++ package to identify patterns and biological process activity in transcriptomic data (2010) (74)
Estimation of sequencing error rates in short reads (2012) (74)
The Stroke Prevention Policy Model: Linking Evidence and Clinical Decisions (1997) (70)
Searching for differentially expressed gene combinations (2005) (68)
On Optimal Screening Ages (1993) (66)
Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutations (2004) (65)
Consensus on Molecular Subtypes of High-Grade Serous Ovarian Carcinoma (2018) (63)
Validity of Models for Predicting BRCA1 and BRCA2 Mutations (2007) (63)
Congenital growth hormone (GH) deficiency and atherosclerosis: effects of GH replacement in GH-naive adults. (2007) (63)
Cross-study validation and combined analysis of gene expression microarray data. (2007) (62)
Transcriptome Deconvolution of Heterogeneous Tumor Samples with Immune Infiltration (2017) (61)
Influenza Vaccination and COVID19 Mortality in the USA (2020) (60)
Adjustment uncertainty in effect estimation (2008) (59)
Integrating diverse genomic data using gene sets (2011) (58)
Differential and limited expression of mutant alleles in multiple myeloma. (2014) (58)
Diagnostic Measures for Model Criticism (1996) (58)
Evaluation of widely used models for predicting BRCA1 and BRCA2 mutations (2004) (56)
Hidden Markov models for the assessment of chromosomal alterations using high-throughput SNP arrays. (2008) (54)
Relationship Between Bayesian and Frequentist Sample Size Determination (2005) (54)
Web-based tissue microarray image data analysis: initial validation testing through prostate cancer Gleason grading. (2001) (52)
Modeling in Medical Decision Making: A Bayesian Approach (2002) (52)
Precision Prevention and Early Detection of Cancer: Fundamental Principles. (2018) (51)
Assessing Uncertainty in Cost-Effectiveness Analyses (1997) (51)
GAMMA SHAPE MIXTURES FOR HEAVY-TAILED DISTRIBUTIONS (2008) (51)
BRCA 1 Recruitment to Transcriptional Pause Sites Is Required for R-Loop-Driven DNA Damage Repair (51)
Analyzing Health Care Costs: A Comparison of Statistical Methods Motivated by Medicare Colorectal Cancer Charges (2004) (50)
Cost-effectiveness of alternative strategies for integrating MRI into breast cancer screening for women at high risk (2014) (50)
Is axillary lymph node dissection indicated for early-stage breast cancer? A decision analysis. (1999) (49)
Estimating CDKN2A carrier probability and personalizing cancer risk assessments in hereditary melanoma using MelaPRO. (2010) (47)
Penalized likelihood for sparse contingency tables with an application to full-length cDNA libraries (2007) (45)
The ordering of expression among a few genes can provide simple cancer biomarkers and signal BRCA1 mutations (2009) (45)
A Bayesian Model for Cross-Study Differential Gene Expression (2009) (45)
Gene expression variation in the adult human retina. (2004) (44)
Role of stem-cell divisions in cancer risk (2017) (43)
Utility and Means in the 1930s (1993) (43)
Predicting the Cost of Illness (1998) (42)
Accounting for uncertainty in confounder and effect modifier selection when estimating average causal effects in generalized linear models (2015) (42)
Performance of breast cancer risk assessment models in a large mammography cohort. (2019) (41)
Missense mutations in disease genes: a Bayesian approach to evaluate causality. (1998) (41)
Long Intergenic Non-Coding RNAs have an Independent Impact on Survival in Multiple Myeloma (2018) (40)
Abstract GS2-03: Pathological complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and mortality, stratified by breast cancer subtypes and adjuvant chemotherapy usage: Individual patient-level meta-analyses of over 27,000 patients (2019) (40)
Semiparametric regression for count data (2002) (40)
Combining Expert Judgment by Hierarchical Modeling: An Application to Physician Staffing (1998) (39)
I-SPY 2--A Glimpse of the Future of Phase 2 Drug Development? (2016) (39)
Deficiency of different nitric oxide synthase isoforms activates divergent transcriptional programs in cardiac hypertrophy. (2003) (38)
Multi‐study factor analysis (2016) (38)
Family History of Breast or Prostate Cancer and Prostate Cancer Risk (2018) (37)
Combining Information From Related Regressions (1997) (36)
Training replicable predictors in multiple studies (2018) (36)
When should one subtract background fluorescence in 2-color microarrays? (2006) (36)
A Clinical Decision Support Tool to Predict Cancer Risk for Commonly Tested Cancer-Related Germline Mutations (2018) (36)
Bayesian response‐adaptive designs for basket trials (2017) (35)
Deciphering the chronology of copy number alterations in Multiple Myeloma (2019) (35)
A Markov Chain Monte Carlo Technique for Identification of Combinations of Allelic Variants Underlying Complex Diseases (2005) (35)
Más-o-menos: a simple sign averaging method for discrimination in genomic data analysis (2014) (35)
Biomarker-based adaptive trials for patients with glioblastoma--lessons from I-SPY 2. (2013) (34)
A Model-Based Comparison of Breast Cancer Screening Strategies: Mammograms and Clinical Breast Examinations (2005) (34)
Recent Enhancements to the Genetic Risk Prediction Model BRCAPRO (2015) (34)
Measuring uncertainty in complex decision analysis models (2002) (33)
A Bayesian Hierarchical Approach for Combining Case‐Control and Prospective Studies (1999) (33)
Expressed fusion gene landscape and its impact in multiple myeloma (2017) (32)
Bayesian nonparametric cross-study validation of prediction methods (2015) (32)
Multiomic Analysis of Subtype Evolution and Heterogeneity in High-Grade Serous Ovarian Carcinoma (2020) (31)
Identifying differential correlation in gene/pathway combinations (2008) (31)
Model selection and health effect estimation in environmental epidemiology. (2008) (30)
Model averaged double robust estimation (2017) (29)
Opportunities for the Primary Prevention of Colorectal Cancer in the United States (2011) (29)
Simplifying clinical use of the genetic risk prediction model BRCAPRO (2013) (29)
MergeMaid: R Tools for Merging and Cross-Study Validation of Gene Expression Data (2004) (29)
Clinical Factors Associated With Gastric Cancer in Individuals with Lynch Syndrome. (2020) (29)
Expression Profiling of Archival Tumors for Long-term Health Studies (2012) (29)
Using Machine Learning and Natural Language Processing to Review and Classify the Medical Literature on Cancer Susceptibility Genes (2019) (29)
Impact of the cancer risk intake system on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy (2005) (28)
Modeling Liquid Association (2011) (28)
Haplotype block partitioning as a tool for dimensionality reduction in SNP association studies (2008) (28)
Optimal Design for Heart Defibrillators (1995) (27)
Protein construct storage: Bayesian variable selection and prediction with mixtures. (1998) (27)
Genome-Wide Somatic Alterations in Multiple Myeloma Reveal a Superior Outcome Group (2020) (27)
Genetic Susceptibility and Survival: Application to Breast Cancer (2000) (26)
Bayesian Semiparametric Analysis of Developmental Toxicology Data (2001) (26)
Timing medical examinations via intensity functions (1997) (25)
High-Dimensional Confounding Adjustment Using Continuous Spike and Slab Priors. (2017) (25)
Numerical Evaluation of Information- Theoretic Measures (1996) (25)
Association of COVID-19 Vaccination With SARS-CoV-2 Infection in Patients With Cancer (2021) (25)
Penetrance of Breast and Ovarian Cancer in Women Who Carry a BRCA1/2 Mutation and Do Not Use Risk-Reducing Salpingo-Oophorectomy: An Updated Meta-Analysis (2020) (25)
Assessing the added value of breast tumor markers in genetic risk prediction model BRCAPRO (2012) (25)
Influenza Vaccination and COVID-19 Mortality in the USA: An Ecological Study (2021) (25)
Incorporating tumor immunohistochemical markers in BRCA1 and BRCA2 carrier prediction (2008) (24)
Comparing Platforms for Messenger RNA Expression Profiling of Archival Formalin-Fixed, Paraffin-Embedded Tissues. (2015) (24)
Three allele combinations associated with Multiple Sclerosis (2006) (24)
Designing Clinical Trials That Accept New Arms: An Example in Metastatic Breast Cancer. (2017) (24)
Recent BRCAPRO Upgrades Significantly Improve Calibration (2014) (23)
Bayesian multistudy factor analysis for high-throughput biological data (2018) (23)
Shared and Study-specific Dietary Patterns and Head and Neck Cancer Risk in an International Consortium (2019) (23)
A Prospective Study of the Association between Physical Activity and Risk of Prostate Cancer Defined by Clinical Features and TMPRSS2:ERG. (2019) (23)
Validation of a Semiautomated Natural Language Processing-Based Procedure for Meta-Analysis of Cancer Susceptibility Gene Penetrance. (2019) (23)
The Impact of Stroma Admixture on Molecular Subtypes and Prognostic Gene Signatures in Serous Ovarian Cancer (2019) (23)
Assessing reproducibility of a protein dynamics study using in vivo labeling and liquid chromatography tandem mass spectrometry. (2005) (22)
Molecular classification of lung cancer: a cross-platform comparison of gene expression data sets. (2004) (22)
Optimal Scheduling of Fallible Inspections (1996) (22)
MODELING DEPENDENT GENE EXPRESSION. (2012) (22)
Comparative gene expression analysis of murine retina and brain. (2004) (22)
Combining progression-free survival and overall survival as a novel composite endpoint for glioblastoma trials. (2015) (22)
Discussion on the meeting on ‘Statistical modelling and analysis of genetic data’ (2002) (21)
Statistical methods for identifying differentially expressed gene combinations. (2007) (21)
Continuity of transcriptomes among colorectal cancer subtypes based on meta-analysis (2018) (21)
Leveraging molecular datasets for biomarker-based clinical trial design in glioblastoma (2017) (21)
Report on emerging technologies for translational bioinformatics: a symposium on gene expression profiling for archival tissues (2012) (21)
Statistical modeling and visualization of molecular profiles in cancer. (2003) (21)
Multiple diseases in carrier probability estimation: Accounting for surviving all cancers other than breast and ovary in BRCAPRO (2008) (21)
Several Bayesians: A review (1993) (20)
Classification of Missense Mutations of Disease Genes (2005) (20)
Estimating percentile‐specific treatment effects in counterfactual models: a case‐study of micronutrient supplementation, birth weight and infant mortality (2006) (19)
A Note on the Residual Entropy Function (1993) (19)
Tailoring BRCAPRO to Asian-Americans. (2009) (19)
Does the effect of micronutrient supplementation on neonatal survival vary with respect to the percentiles of the birth weight distribution (2007) (19)
GH response to hypoglycemia and clonidine in the GH-releasing hormone resistance syndrome (2006) (18)
Representation via Representations: Domain Generalization via Adversarially Learned Invariant Representations (2020) (18)
Penetrance of Colorectal Cancer Among Mismatch Repair Gene Mutation Carriers: A Meta-Analysis (2020) (18)
Exploring Expected Utility Surfaces by Markov Chains (1996) (18)
A two-stage approach to genetic risk assessment in primary care (2016) (18)
Conjugate analysis of multivariate normal data with incomplete observations (2000) (17)
A Cost-Utility Analysis of Alternative Strategies in Screening for Breast Cancer (1993) (17)
Modeling and Optimization in Early Detection Programs with a Single Exam (2002) (17)
Adding experimental arms to platform clinical trials: randomization procedures and interim analyses. (2018) (17)
Estimating distribution of age of the onset of detectable asymptomatic cancer (2001) (16)
Modeling Risk of Breast Cancer and Decisions about Genetic Testing (1999) (16)
POE: Statistical Methods for Qualitative Analysis of Gene Expression (2003) (16)
Providing access to risk prediction tools via the HL7 XML-formatted risk web service (2013) (15)
Frailty Models for Familial Risk With Application to Breast Cancer (2013) (15)
Changes in Utility as Information (2010) (15)
Importance of Different Types of Prior Knowledge in Selecting Genome‐Wide Findings for Follow‐Up (2013) (15)
Validating Bayesian Prediction Models: a Case Study in Genetic Susceptibility to Breast Cancer (1999) (15)
The Doppelgänger Effect: Hidden Duplicates in Databases of Transcriptome Profiles. (2016) (15)
SNP Prioritization Using a Bayesian Probability of Association (2013) (15)
Accuracy of MSI testing in predicting germline mutations of MSH2 and MLH1: a case study in Bayesian meta-analysis of diagnostic tests without a gold standard. (2005) (15)
Applications of Lindley Information Measure to the Design of Clinical Experiments (1994) (15)
Multivariate Analysis and Visualization of Splicing Correlations in Single-Gene Transcriptomes (2007) (15)
High-Dose Melphalan Significantly Increases Mutational Burden in Multiple Myeloma Cells at Relapse: Results from a Randomized Study in Multiple Myeloma (2020) (14)
Response to Comments on "The Consensus Coding Sequences of Human Breast and Colorectal Cancers" (2007) (13)
A Multiple-Loop, Double-Cube Microarray Design Applied to Prostate Cancer Cell Lines with Variable Sensitivity to Histone Deacetylase Inhibitors (2008) (13)
Combining Studies with Continuous and Dichotomous Responses: A Latent-Variables Approach (2000) (13)
Calibrated predictions for multivariate competing risks models (2014) (12)
Reassessing risk models for atypical hyperplasia: age may not matter (2017) (12)
Clustering and Classification Methods for Gene Expression Data Analysis (2004) (12)
The impact of different sources of heterogeneity on loss of accuracy from genomic prediction models (2018) (12)
Minimax, information and ultrapessimism (1992) (12)
Propensity scores with misclassified treatment assignment: a likelihood‐based adjustment (2017) (12)
When Should One Substract Background Fluorescence in Two Color Microarrays (2005) (12)
STATISTICAL METHODS FOR THE ANALYSIS OF CANCER GENOME SEQUENCING DATA (2007) (11)
Gene expression variation in the adult human retina (2003) (11)
DESIGNING OBSERVATION TIMES FOR INTERVAL CENSORED DATA (1998) (11)
Modular network construction using eQTL data: an analysis of computational costs and benefits (2014) (11)
Orthogonalizations and Prior Distributions for Orthogonalized Model Mixing (1996) (11)
Decision Theory: Bayesian (2001) (11)
Designing Follow-Up Times (2002) (10)
Robustifying genomic classifiers to batch effects via ensemble learning (2019) (10)
Evaluating a 4‐marker signature of aggressive prostate cancer using time‐dependent AUC (2015) (10)
Bayesian Model Criticism (1993) (9)
Likelihood Estimation of Conjugacy Relationships in Linear Models with Applications to High-Throughput Genomics (2009) (9)
Combining Bayesian experimental designs and frequentist data analyses: motivations and examples (2017) (9)
Tree-Weighting for Multi-Study Ensemble Learners (2019) (9)
Optimal Inspection and Replacement Policies with Age-Dependent Failures and Fallible Tests (1993) (9)
Uncertainty and the value of diagnostic information, with application to axillary lymph node dissection in breast cancer (2004) (9)
Pre-analysis of superlarge industrial data sets (1992) (8)
False discovery rates in somatic mutation studies of cancer (2011) (8)
Inspection times for stand-by units (1994) (8)
IgM-MM is predominantly a pre-germinal center disorder and has a distinct genomic and transcriptomic signature from WM. (2021) (8)
The penetrance of ductal carcinoma in situ among BRCA1 and BRCA2 mutation carriers (2012) (8)
Rejoinder: Bayesian Effect Estimation Accounting for Adjustment Uncertainty (2012) (8)
The Integrative Correlation Coefficient: a Measure of Cross-study Reproducibility for Gene Expressionea Array Data (2007) (7)
Cross-Calibration of Stroke Disability Measures (2003) (7)
Hierarchical Bayesian analysis of somatic mutation data in cancer (2013) (7)
Cross-study learning for generalist and specialist predictions (2020) (7)
Drs. Harrington and Parmigiani reply (2016) (6)
Optimization of Breast Cancer Screening Modalities (2006) (6)
Efficient computation of the joint probability of multiple inherited risk alleles from pedigree data (2018) (6)
Identification of Gene Expression Changes Associated with the Progression of Retinal Degeneration in the rd 1 Mouse (2004) (6)
A Decision‐Theory Approach to Interpretable Set Analysis for High‐Dimensional Data (2013) (6)
Multiple Model Evaluation Absent the Gold Standard Through Model Combination (2008) (6)
Breast and Colorectal Cancers The Consensus Coding Sequences of Human (2007) (6)
Assessing the benefits of testing for breast cancer susceptibility genes: a decision analysis. (1998) (6)
Merging versus Ensembling in Multi-Study Machine Learning: Theoretical Insight from Random Effects (2019) (6)
Extending Mendelian Risk Prediction Models to Handle Misreported Family History (2014) (6)
Integrative correlation: Properties and relation to canonical correlations (2014) (6)
Multiplex Immunofluorescence in Formalin-Fixed Paraffin-Embedded Tumor Tissue to Identify Single-Cell–Level PI3K Pathway Activation (2020) (6)
Optimal Bayesian adaptive trials when treatment efficacy depends on biomarkers (2016) (6)
Alternative Splicing Is a Frequent Event and Impacts Clinical Outcome in Myeloma: A Large RNA-Seq Data Analysis of Newly-Diagnosed Myeloma Patients (2014) (5)
Nonparametric Adjustment for Measurement Error in Time-to-Event Data: Application to Risk Prediction Models (2018) (5)
Validation of Breast Cancer Risk Models by Race/Ethnicity, Family History and Molecular Subtypes (2021) (5)
OPTIMIZED CROSS-STUDY ANALYSIS OF MICROARRAY-BASED PREDICTORS (2007) (5)
Frequentist operating characteristics of Bayesian optimal designs via simulation (2019) (5)
Glioblastoma Multiforme An Integrated Genomic Analysis of Human (2010) (5)
LSD1 Impairs the Epithelial-Mesenchymal Transition (EMT) and Osteoclastogenesis Potency in Multiple Myeloma and Synergistically Induces Cytotoxicity with HDAC Inhibitors (2014) (5)
Hierachical Resampling for Bagging in Multi-Study Prediction with Applications to Human Neurochemical Sensing (2019) (5)
A Statistical Analysis of Radiolabeled Gene Expression Data (2001) (5)
Reclassification of predictions for uncovering subgroup specific improvement (2014) (4)
Completing the Results of the 2013 Boston Marathon (2014) (4)
Advances in Brief Detection of Mitochondrial DNA Mutations in Pancreatic Cancer Offers a “ Mass ”-ive Advantage over Detection of Nuclear DNA Mutations 1 (2001) (4)
A dirichlet process elaboration diagnostic for binomial goodness of fit (1998) (4)
A HIDDEN MARKOV MODEL FOR JOINT ESTIMATION OF GENOTYPE AND COPY NUMBER IN HIGH-THROUGHPUT SNP CHIPS (2007) (4)
Generalized Quantile Treatment Effect: A Flexible Bayesian Approach Using Quantile Ratio Smoothing (2015) (4)
Identification of a Novel Long Intergenic Noncoding RNA - Linc00936, with Significant Impact on Multiple Myeloma Cell Growth Via mTOR Pathway Inhibition (2015) (4)
TRAB: Testing Whether Mutation Frequencies Are Above an Unknown Background (2008) (4)
The impact of stroma on the discovery of molecular subtypes and prognostic gene signatures in serous ovarian cancer (2018) (4)
Estimating the Effects of Fine Particulate Matter on 432 Cardiovascular Diseases Using Multi-Outcome Regression With Tree-Structured Shrinkage (2020) (4)
Estimating Percentile-Specific Causal Effects: A Case Study of Micronutrient Supplementation, Birth Weight, and Infant Mortality (2004) (4)
Appendix B: Glossary (2008) (4)
Quantitative models for predicting mutations in Lynch syndrome genes (2007) (3)
Author Correction: Adaptive platform trials: definition, design, conduct and reporting considerations (2019) (3)
Generalized Quantile Treatment Effect (2014) (3)
Response to Comments on “The Predictive Capacity of Personal Genome Sequencing” (2012) (3)
Simulation Approach to One-Stage and Sequential Optimal Design Problems (1995) (3)
Sparse Contingency Tables and High-Dimensional Log-Linear Models for Alternative Splicing in Full-Length cDNA Libraries (2006) (3)
P53 Is axillary lymph node dissection indicated for early stage breast cancer? A decision analysis (1998) (3)
Combining Breast Cancer Risk Prediction Models (2020) (3)
GENERALIZED LIQUID ASSOCIATION (2009) (3)
Familial Cancer Risk Assessment Using BayesMendel (2010) (3)
Adjustment for Mismeasured Exposure using Validation Data and Propensity Scores (2014) (3)
Screening for Differentially Expressed Genes: Are Multilevel Models Helpful? (2013) (3)
Misreported family histories and underestimation of risk. (2014) (3)
Consensus on Molecular Subtypes of Ovarian Cancer (2017) (3)
Limited family structure and breast cancer risk. (2007) (3)
Landscape of Recurrent Mutations in Non-Coding Genome with Functional Implications in Newly-Diagnosed Multiple Myeloma (2018) (3)
Ask2Me VarHarmonizer: A Python-Based Tool to Harmonize Variants from Cancer Genetic Testing Reports and Map them to the ClinVar Database (2019) (3)
Diagnostic Measures for Model (1993) (3)
Statistical methods for automated drug susceptibility testing: Bayesian minimum inhibitory concentration prediction from growth curves (2009) (3)
Nuclease Activity Is Associated with Genomic Instability As Well As Survival in Myeloma; Underlying Mechanisms and Significance (2015) (2)
A nested unsupervised approach to identifying novel molecular subtypes (2004) (2)
Validity and Relative Validity of Alternative Methods to Assess Physical Activity in Epidemiologic Studies: Findings from the Men's Lifestyle Validation Study. (2022) (2)
The Multiple Myeloma Genome Project: Development of a Molecular Segmentation Strategy for the Clinical Classification of Multiple Myeloma (2016) (2)
Statistical tools and R software for cancer driver probabilities. (2014) (2)
High Throughput Genomic Analysis Identifies Low-Risk Smoldering Multiple Myeloma (2020) (2)
Why tyrosine kinase inhibitor resistance is common in advanced gastrointestinal stromal tumors (2013) (2)
Redefining Mutational Profiling Using RNA-Seq: Insight into the Functional Mutational Landscape of Multiple Myeloma (2015) (2)
Cross-platform Comparison of Two Pancreatic Cancer Phenotypes (2010) (2)
Covariate-Profile Similarity Weighting and Bagging Studies with the Study Strap: Multi-Study Learning for Human Neurochemical Sensing (2019) (2)
Differentially Expressed and Prognostically Significant Lincrnas May Impact Immune System and Tumor Progression in Multiple Myeloma (MM) (2015) (2)
OnionTree XML: A Format to Exchange Gene-Related Probabilities (2011) (2)
S4-4: Clarifying the Risk of Breast Cancer in Women with Atypical Breast Lesions. (2011) (2)
Statistical methods for Mendelian models with multiple genes and cancers (2021) (2)
Practical implementation of frailty models in Mendelian risk prediction. (2020) (2)
Multi-omic analysis of subtype evolution and heterogeneity in high-grade serous ovarian carcinoma (2019) (2)
Pathologic findings in reduction mammoplasty procedures identified by natural language processing of breast pathology reports: A surrogate for the population incidence of cancer and high risk lesions. (2018) (2)
Integrative factor analysis - An unsupervised method for quantifying cross-study consistency of gene expression data. (2017) (2)
Receiver operating characteristic curves with an indeterminacy zone (2020) (2)
Next Generation Sequencing in Multiple Myeloma (2015) (2)
Power Conjugate Multilevel Models with Applications to Genomics (2004) (2)
Variation in cancer risk among families with genetic susceptibility (2020) (2)
Inference and Design Strategies for a Hierarchical LogisticRegression Model (2018) (1)
Statistical Properties of the Integrative Correlation Coefficient: a Measure of Cross-study Gene Reproducibility (2011) (1)
Estimation of sequencing error rates in short reads (2012) (1)
Genome Wide Transcriptomic Analysis Identifies Dysregulated Splicing Factor Profile with Molecular and Functional Role in Multiple Myeloma (2019) (1)
Report on emerging technologies for translational bioinformatics: a symposium on gene expression profiling for archival tissues (2012) (1)
Shared and study-specific dietary patterns (2018) (1)
Meta-analysis of public microarray databases for prognostic and predictive gene signatures of late-stage ovarian cancer. (2014) (1)
Bayesian Combinatorial Multi-Study Factor Analysis (2020) (1)
Legacy Genetic Testing Results for Cancer Susceptibility: How Common are Conflicting Classifications in a Large Variant Dataset from Multiple Practices? (2020) (1)
XDE : A Bayesian hierarchical model for analysis of differential expression in multiple studies (2008) (1)
Statistical approaches for meta‐analysis of genetic mutation prevalence (2020) (1)
Wiley Series in Probability and Statistics (2009) (1)
Gene Expression Pathways in Prostate Tissue Associated with Vigorous Physical Activity in Prostate Cancer (2021) (1)
A BAYESIAN APPROACH TO EFFECT ESTIMATION ACCOUNTING FOR ADJUSTMENT UNCERTAINTY (2008) (1)
Defining Genomic Probability of Progression to Identify Low-Risk Smoldering Multiple Myeloma (2021) (1)
Inadequate Sars-Cov-2 Vaccine Effectiveness in Patients with Multiple Myeloma: A Large Nationwide Veterans Affairs Study (2021) (1)
Cross-Study Replicability in Cluster Analysis (2022) (1)
Abstract 2543: A family affair: Prostate cancer risk and family history of breast or prostate cancer (2016) (1)
Bioinformatic Analysis of Epidemiological and Pathological Data (2017) (1)
Frequent Igh Fusion Transcripts with Clinical Impact in Multiple Myeloma (2014) (1)
Reply to B. Freidlin et al. (2013) (1)
Loss of ribonuclease DIS3 hampers genome integrity in myeloma by disrupting DNA:RNA hybrid metabolism (2022) (1)
1562MO Effectiveness of COVID-19 vaccination in cancer patients: A nationwide Veterans Affairs study (2021) (1)
Extent, impact, and mitigation of batch effects in tumor biomarker studies using tissue microarrays (2021) (1)
Calibrated predictions for multivariate competing risks models (2013) (1)
Extending models via gradient boosting: An application to Mendelian models (2021) (1)
Family history of prostate cancer and the incidence of ERG‐ and phosphatase and tensin homolog‐defined prostate cancer (2019) (1)
Multi-Study Learning for Real-time Neurochemical Sensing in Humans using the ``Study Strap Ensemble" (2021) (1)
[Genetic predisposition to multiple sclerosis as a polygenic autoimmune disease]. (2009) (1)
Gene set enrichment analysis of prostate cancer cells to study histone deacetylase inhibitor resistance (2007) (1)
Evaluation of Lynch syndrome risk models in a multicenter diverse population. (2022) (1)
A Detailed Alternate Splicing Landscape in Multiple Myeloma with Significant Potential Biological and Clinical Implications (2016) (1)
Table 17, MammaPrint® compared with traditional composite risk markers (2008) (0)
Table 3, Evidence Table. Analytic validity, Oncotype DX™ (2008) (0)
Adding Experimental Arms to Ongoing Clinical Trials (2016) (0)
OAB-021: High-risk multiple myeloma due to extramedullary disease-like gene expression induced by bone marrow stromal cells (2022) (0)
[Immunoglobulins in lymphomas: quantitative determinations and detection of molecular dysmetabolic changes]. (1972) (0)
Table 10, Evidence Table. Study design, H/I ratio (2008) (0)
Table 4, Analytic validity, Oncotype DX™ (2008) (0)
AMultiple-Loop , Double-CubeMicroarray Design Applied to Prostate Cancer Cell Lines withVariable Sensitivity to Histone Deacetylase Inhibitors (2008) (0)
[Table], MAMMAPRINT®: the 70-gene signature (2008) (0)
Appendix C: Description of Genes (2008) (0)
Table 9, Successful assays, two-gene signature and H/I ratio assays (2008) (0)
Appendix A: List of Acronyms (2008) (0)
MCMC METHOD HAS FOUND THAT MULTIPLE SCLEROSIS IS ASSOCIATED WITH TWO-THREE GENES COMBINATIONS (2004) (0)
Table 5, RT-PCR vs IHC comparison assays, Oncotype DX™ (2008) (0)
Nuclear DNA Mutations Cancer Offers a ' ' Mass ' '-ive Advantage over Detection of Detection of Mitochondrial DNA Mutations in Pancreatic Updated (2001) (0)
Table 19, Clinical Utility, Oncotype DX™ (2008) (0)
Table 18, Clinical Validity, two-gene signature and H/I ratio assays (2008) (0)
Table 3, Variability and reproducibility, Oncotype DX™ (2008) (0)
PanelPRO: A R package for multi-syndrome, multi-gene risk modeling for individuals with a family history of cancer (2020) (0)
Appendix G: Title Review Forms (2008) (0)
[Clinico-statistical note on 2000 cesarean sections for 1954 to 1964]. (1966) (0)
Discovery and validation of a 30-gene expression signature to identify prostate cancer patients who are candidates for active surveillance. (2015) (0)
OAB-017: Mutations accumulated before and after hyperdiploidy reveal timing and impact of chromosomal gains on multiple myeloma (2022) (0)
The Average Baseline BCR-ABL Levels Are Significantly Higher in Patients with Resistance to Dasatinib As First-Line Treatment for Early Chronic Phase Chronic Myeloid Leukemia (2012) (0)
Long Intergenic Non-Coding RNAs (lincRNA) Impacts Biology and Clinical Outcome in Multiple Myeloma (2014) (0)
The Genomic, Epigenomic, and Psychosocial Characteristics of Long-Term Survivors of Ovarian Cancer (2015) (0)
Functional and Clinical Impact of Splicing Factor Dysregulation in Multiple Myeloma (2015) (0)
In reply [13] (2007) (0)
Functional and Clinical Relevance of Splicing Factor SRSF1 in Multiple Myeloma (MM) (2014) (0)
Abstract 2355: Risk prediction for late-stage ovarian cancer by meta-analysis of 1,525 patient samples (2014) (0)
Epigenetic Profiling and Epigenetic Therapy in Cancer (2008) (0)
Estimation of sequencing error rates in short (2012) (0)
Comparing Platforms for Messenger RNA Expression Pro fi ling of Archival Formalin-Fixed , 77 78 79 80 81 82 83 Paraf fi n-Embedded Tissues (2015) (0)
Genomic Landscape Predictive of Minimal Residual Disease (MRD) in Multiple Myeloma (MM) (2015) (0)
A likelihood‐based approach to assessing frequency of pathogenicity among variants of unknown significance in susceptibility genes (2020) (0)
Table 15, Risk classification of Oncotype DX™ against the Adjuvant! guidelines (2008) (0)
Gene Expression Profiling in Human Retina using a Retina Custom cDNA Microarray (2002) (0)
Assessing the added value of breast tumor markers in breast cancer genetic risk prediction model BRCAPRO. (2011) (0)
[Effect of heparin therapy on blood and bone marrow levels of cells with basophilic granulations]. (1956) (0)
Table 11, Evidence Table. Study population characteristics, H/I ratio (2008) (0)
Abstract B045: Gene expression pathways associated with vigorous physical activity in prostate cancer (2018) (0)
Identification of a Gene Expression Profile That Differentiates Between Ischemic and Nonischemic Cardiomyopathy Heart Failure (2004) (0)
Inferring Coordinated Gene Activity in Pattern Sets (2011) (0)
Bayesian Design for Random Walk Barriers (2009) (0)
Table 8, Analytic validity, MammaPrint® (2008) (0)
Table 10, Reproducibility, two-gene signature and H/I ratio assay (2008) (0)
Table 6, Evidence Table. Study design, MammaPrint® (2008) (0)
Comment (2016) (0)
Abstract 5719: Long intergenic non-coding RNAs: a new independent risk predictors in multiple myeloma (2017) (0)
Appendix I: Evidence Tables (2008) (0)
PENALIZED LIKELIHOOD AND BAYESIAN METHODS FOR SPARSE CONTINGENCY TABLES: AN ANALYSIS OF ALTERNATIVE SPLICING IN FULL-LENGTH cDNA LIBRARIES (2006) (0)
Leary Patients with Whole-Genome Sequencing Detection of Chromosomal Alterations in the Circulation of Cancer (2012) (0)
Retinal Gene Expression Alterations in Age Related Macular Degeneration (2005) (0)
The Landscape of Genome Wide Somatic Alterations Identifies a Good-Risk Group in Newly Diagnosed Multiple Myeloma (2019) (0)
Table 11, RT-PCR vs IHC comparison assays, two-gene signature and H/I ratio assays (2008) (0)
[Table], BCP - H/I assay: 2-gene signature and normalizing genes (2008) (0)
COMBINATIONAL MIXTURES OF MULTIPARAMETER DISTRIBUTIONS (2007) (0)
hypertrophy activates divergent transcriptional programs in cardiac Deficiency of different nitric oxide synthase isoforms (2003) (0)
Logistic push: a regression framework for partial AUC optimization (2016) (0)
Table 12, Evidence Table. Analytic validity, H/I ratio (2008) (0)
RNA-Seq De Novo Assembly of Clonal Immunoglobulin Rearrangements Identifies Interesting Biology and Uncovers Prognostic Features in Multiple Myeloma (2016) (0)
Table 21, Clinical Utility, two-gene signature and H/I ratio (2008) (0)
Cross-Cluster Weighted Forests (2021) (0)
Table 1, Description of the three gene expression profile assays (2008) (0)
Table 9, Evidence Table. Clinical utility and validity, MammaPrint® (2008) (0)
10-3-2007 MULTIPLE MODEL EVALUATION ABSENT THE GOLD STANDARD VIA MODEL COMBINATION (2018) (0)
Table 7, Reproducibility, MammaPrint® (2008) (0)
MyLynch: A Patient-Facing Clinical Decision Support Tool for Genetically-Guided Personalized Medicine in Lynch Syndrome (2023) (0)
Rejoinder (2009) (0)
Table 13, Risk classification of Oncotype DX™ against the St. Gallen criteria (2008) (0)
Nucleotide Excision Repair (NER) Is Frequently Impaired and Affects Outcome in Multiple Myeloma (MM) (2014) (0)
Table 2, Evidence Table. Study population characteristics, Oncotype DX™ (2008) (0)
[Screening for serum hepatitis in a non-ambulatory hospital population]. (1971) (0)
Recurrent somatic Alterations in the Non-Coding Genome Alter Gene Expression Levels and Correlate With Clinical Outcome (2019) (0)
Table 16, Clinical Validity, MammaPrint® and 70-gene signature (2008) (0)
Comparing and assessing the reported penetrance of cancer susceptibility genes for breast cancer. (2020) (0)
3' Untranslated Region (UTR) Alterations Are Frequently Targeted By MM-Related Mirnas and Affects the Clinical Outcome (2016) (0)
Table 14, Risk classification of Oncotype DX™ against the 2004 NCCN guidelines (2008) (0)
WW14: MAKING MODELS BETTER (2001) (0)
Somatic Changes Prior to the Development of Hyperdiploidy Expose Mutation Accumulation Rate and Activated Processes in Multiple Myeloma (2022) (0)
Telomerase Contributes To Repair Of DNA Breaks In Myeloma Cells By Incorporating “TTAGGG” Sequences Within Genome: Biological and Translational Significance (2013) (0)
Appendix F: Detailed Electronic Database Search Strategies (2008) (0)
Individualized screening decision tool for HNPCC (2007) (0)
Table 6, Successful assays, MammaPrint® (2008) (0)
Table 20, Comparison of economic studies (2008) (0)
A First In-Depth Analysis of Alternate Splicing Landscape in Multiple Myeloma with Significant Potential Biological and Clinical Implications (2019) (0)
[Further simplification of the method of immunoelectrophoresis]. (1971) (0)
Pancreatic imaging findings from the PRECEDE study: A large high-risk heritable cohort for pancreatic cancer. (2023) (0)
Table 7, Evidence Table. Study population characteristics, MammaPrintsup® (2008) (0)
Abstract SY32-01: Knowledge management and decision support for commonly tested susceptibility mutations (2018) (0)
Merging versus Ensembling in Multi-Study Prediction: Theoretical Insight from Random Effects (2019) (0)
[Report on 6-month use of the Coulter Counter, model S]. (1971) (0)
Table 1, Evidence Table. Study design, Oncotype DX™ (2008) (0)
Prognostic and Predictive Markers in Metastatic Renal Cell Carcinoma (2013) (0)
Bayesian Multi-Study Non-Negative Matrix Factorization for Mutational Signatures (2023) (0)
Modeling cell-free DNA fragment size densities for non-invasive detection of cancer. (2021) (0)
Abstract B83: The prevalence of colorectal cancer risk factors in the United States, 1999-2008 (2010) (0)
Clinical implications of conflicting variant interpretations in the cancer genetics clinic. (2023) (0)
Dysregulated Mirnas after Uniform Treatment Predict Outcome of Newly-Diagnosed Multiple Myeloma (2019) (0)
Abstract 893: Batch effects in tumor biomarker studies using tissue microarrays: Extent, impact, and remediation (2021) (0)
Defining Replicability of Prediction Rules (2023) (0)
Table 8, Evidence Table. Analytic validity, MammaPrint® (2008) (0)
In reply [5] (2007) (0)
Multi-Study Boosting: Theoretical Considerations for Merging vs. Ensembling (2022) (0)
Table 13, Evidence Table. Clinical utility and validity, H/I ratio (2008) (0)
The Fusion Gene Landscape in Multiple Myeloma, with Clinical Impact (2015) (0)
Combinatorial Mixtures of Multiparameter Distributions: An Application to Bivariate Data (2017) (0)
Bayesian Response-Adaptive Designs for Basket Trials 3 (2017) (0)
[Figure], Figure 3. Schematic model for microarray hybridizations. Panel A: two-color scheme design. Panel B: single-color design (2008) (0)
S119 THE ROLE OF RECURRENT SOMATIC ALTERATIONS IN THE NON-CODING GENOME WITH FUNCTIONAL IMPLICATIONS IN MM (2019) (0)
Limits to the Human Cancer Genome Project ? (0)
Bayesian Meta-Analysis of Penetrance for Cancer Risk (2023) (0)
Appendix H: Excluded Articles (2008) (0)
Bone Marrow Microenvironment Regulates Alternative Splicing Events in Myeloma Cells through Downregulation of RNA Binding Protein Fox2 (2014) (0)
Utility in Action (2010) (0)
Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancer (2017) (0)
Screening for serum hepatitis among a hospital in-patient population. (1971) (0)
Appendix A: Technical Experts and Peer Reviewers (2008) (0)
MP79-02 DISCOVERY OF A GENE EXPRESSION SIGNATURE OF PROSTATE CANCER PROGNOSTICATION BY FOCUSING ON INDOLENT TUMORS (2014) (0)
Abstract IA06: The Long-Term Ovarian Cancer Survivor Project: A Department of Defense initiative (2020) (0)
A Theoretical View of Adversarial Domain Generalization in the Hierarchical Model Setting (2021) (0)
In reply [8] (2007) (0)
Multi-Task Learning for Sparsity Pattern Heterogeneity: A Discrete Optimization Approach (2022) (0)
[Table], ONCOTYPE™: the 21-gene signature (2008) (0)
Abstract 2353: A comparative meta-analysis of prognostic gene signatures for late-stage ovarian cancer (2014) (0)
The Fuzzy ROC (2019) (0)
Splicing fator SRSF1 is dsregulated in Multiple Myeloma With Functional and Clinical Significance (2017) (0)
Deciphering the chronology of copy number alterations in Multiple Myeloma (2018) (0)
Table 2, Successful assays, Oncotype DX™ (2008) (0)
Shared and study-specific dietary patterns: a novel approach to replicability and validity (2018) (0)
Abstract B024: Family history of prostate cancer and the incidence of ERG- and PTEN-defined prostate cancer (2018) (0)
In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors (2022) (0)
HealthPolicy 7-3-2018 Consensus on Molecular Subtypes of High-grade Serous Ovarian Carcinoma (2019) (0)
Table 4, Evidence Table. Clinical utility and validity, Oncotype DX™ (2008) (0)
OAB-043: Progression and probability of progression are driven by different genomic features in precursor conditions in myeloma (2021) (0)
Optimal Ensemble Construction for Multi-Study Prediction with Applications to COVID-19 Excess Mortality Estimation (2021) (0)
High-Dose Melphalan Treatment Significantly Increases Mutational Burden at Relapse in Multiple Myeloma. (2023) (0)
Gene may predict aggressive ovarian cancer (2005) (0)
A validation of models for prediction of pathogenic variants in mismatch repair genes. (2022) (0)
Variant-specific Mendelian Risk Prediction Model (2023) (0)
S120 CHRONOLOGY OF COPY NUMBER ALTERATIONS FROM PRECURSORS TO MULTIPLE MYELOMA: WHAT COMES FIRST? (2019) (0)
Abstract PR06: Using frailty models to improve familial cancer risk prediction (2017) (0)
Continuity of transcriptomes among colorectal cancer subtypes based on meta-analysis (2018) (0)
Web-based Supplementary Materials for “Bayesian Response-Adaptive Designs for Basket Trials” by Steﬀen Ventz ∗ , (2017) (0)
Lack of Significant Differences in Somatic Alterations between MGUS, SMM and Symptomatic Multiple Myeloma: A Result from Comprehensive Genomic Profiling Study (2019) (0)
Expressed fusion gene landscape and its impact in multiple myeloma (2017) (0)
Multi-omic analysis supports a developmental hierarchy of molecular subtypes in high-grade serous ovarian carcinoma (2019) (0)
Appendix D: Technologies (2008) (0)
Bayesian multi-study factor model (2016) (0)
Table 12, Clinical validity, Oncotype DX™ (2008) (0)
Supplementary Issue: Computer Simulation, Bioinformatics, and Statistical Analysis of Cancer Data and Processes (2015) (0)
Genomic and Transcriptomic Characterization of IgM Multiple Myeloma Identifies a Pre-Germinal Center Plasma Cell Disorder with Immature B-Cell Transcription-Factor Signature (2020) (0)
covid19census: U.S. and Italy COVID-19 metrics and other epidemiological data (2021) (0)
Prediction of Hereditary Cancers Using Neural Networks (2021) (0)
Molecular characterization of Crohn's disease (Cd) subtypes by microarray transcript profiling of biopsy tissues: Implications for diagnosis and follow up (2003) (0)
[Figure], Figure 1. Increasing complexity of information from genome to transcriptome and proteome: gene expression profiling focuses on the analysis of the transcriptome (2008) (0)
Ramsey and Savage (2010) (0)
Abstract A045: All happy families are alike: Transcriptomic homogeneity in indolent prostate tumors is a useful prognostic biomarker (2018) (0)
A risk prediction tool for individuals with a family history of breast, ovarian, or pancreatic cancer: BRCAPANCPRO (2021) (0)
Table 5, Evidence Table. Critical appraisal of economic analyses of breast cancer gene expression testing (2008) (0)
The Genomic Epigenomic, and Quality-of-Life Charteristics of Long-Term Survivors of Ovarian Cancer (2017) (0)

This paper list is powered by the following services:

Other Resources About Giovanni Parmigiani

What Schools Are Affiliated With Giovanni Parmigiani?

Giovanni Parmigiani is affiliated with the following schools:

Giovanni Parmigiani's Academic­Influence.com Rankings

Giovanni Parmigiani's Degrees

Why Is Giovanni Parmigiani Influential?

Giovanni Parmigiani's Published Works

Published Works

Other Resources About Giovanni Parmigiani

What Schools Are Affiliated With Giovanni Parmigiani?

Giovanni Parmigiani's AcademicInfluence.com Rankings